Page 2 - Industry Insights
-
January 10, 2024Posted: January 10, 2024Categories: Modern Innovations, Clinical, Industry Insights, Case & Study Reviews, Health & Wellness, MicrobiologyComments: 1Read MoreHepatitis C is the primary cause of liver cancer and the need for liver transplants among patients infected with the virus.
Infection is often the result of coming into contact with contaminated blood, usually through injected drug use, but also...
-
January 04, 2024Posted: January 04, 2024Read MoreCarbapenem-resistant Enterobacterales or CRE, are a group of gram-negative bacteria that are resistant to “last line” antibiotics and are very challenging to treat. These microorganisms may confer their resistance via the production of a carbapenemase, an enzyme that inactivates carbapenem antibiotics.
The five most common types of carbapenemases are KPC,...
-
October 09, 2023Posted: October 09, 2023 -
September 20, 2023Posted: September 20, 2023Read MoreHydrogen peroxide vapors utilized in patient hospital rooms may be a significant way to control this deadly disease.
The 2019 edition of the Center for Disease Control and Prevention’s Antibiotic Resistance Threats Report estimated that Clostridioides difficile is responsible...
-
September 08, 2023Posted: September 08, 2023Read MoreMay 11th of 2023 marked the end of both the public health emergency and the national state of emergency for the COVID-19 pandemic. However, health professionals are concerned with the rise of the EG.5 variant, an up-and-coming SARS-CoV-2 strain that is potentially more transmissible than any of the current circulating strains in the United States. (1) EG.5 is a descendant of the Omicron lineage XBB.1.9.5...
-
April 06, 2023Posted: April 06, 2023Read MoreHow could anything so cute be so dangerous?
Antimicrobial resistance (AMR) is one of the top ten global public health threats facing humanity.¹
Ironically, humans are to blame; yet, in recent years, the increase of AMR strains in animals, specifically companion animals...
-
January 20, 2023Posted: January 20, 2023Read MoreClostridioides difficile (formerly named Clostridium difficile, and widely known as C. diff) is a Gram-positive, spore-forming, obligate anaerobe that causes life-threatening diarrhea in people who take antibiotics, are hospitalized or in nursing homes, and people with weakened immune systems.(1)
...
-
November 21, 2022Posted: November 21, 2022Read MoreTwo years ago, there was virtually no flu season due to COVID-19 isolation.
In addition, experts predict another COVID-19 surge this fall and winter.(2) According to the World Health Organization’s early October global situation report, more than 1.5 million COVID-19 diagnosis were reported across Europe during the week ending Oct. 2, about...
-
September 30, 2022Posted: September 30, 2022Categories: Clinical, Industry Insights, Public Health Alerts, Health & Wellness, Product SpotlightsRead MoreEmerging hand in hand with the Pandemic...
A new 2022 special report from the CDC is sounding the alarm that antimicrobial resistance to some of the most concerning bacteria and fungi significantly increased during the COVID-19 pandemic (1) One such highly drug resistant yeast noted in the report is Candida...
-
August 19, 2022Posted: August 19, 2022Read MoreEffective vaccinations for COVID-19 have been readily available in the United States for well over a year and a new vaccine has just been added to the arsenal. Novavax (NVX-CoV2373), created by a company of the same name, was granted emergency use authorization in early July and has now been endorsed by the CDC.(2) Novavax is approved for adults who are 18 years and older and currently is limited to...
-
August 05, 2022Posted: August 05, 2022Read MoreGroup A Streptococcus (GAS) is the most common bacterial cause of pharyngitis, often referred to as strep throat. GAS can also cause severe invasive infections. People who are elderly, have skin breakdown (when the skin is deprived of blood flow, the skin can become damaged or develop ulcers), or have chronic medical conditions, such as diabetes, are at increased risk. Each year in the United States...
-
March 21, 2022Posted: March 21, 2022Categories: Modern Innovations, Clinical, Industry Insights, Public Health Alerts, Health & WellnessRead MoreAs the COVID-19 pandemic moves into its third year, new treatment options to combat the coronavirus disease are being authorized by the U.S. Food and Drug Administration. In December, 2021, the FDA issued emergency use authorization (EUA) for two oral antiviral treatments for COVID-19, Molnupiravir and Paxlovid.(1,2)
This comes at a crucial time in the pandemic as new variants emerge and COVID-19... -
February 10, 2022Posted: February 10, 2022Read MoreHow dangerous are the BA.2 and BA.3 sub-variants compared to the Omicron BA.1 that we already know?
South Africa has one of the most robust public health systems in the world, carefully monitoring their SARS-CoV-2 case load, which has been dominated these last few months by the Delta variant. In recent months, however...
-
January 31, 2022Posted: January 31, 2022Read MoreProbiotics found to assist in restoring normal immune function...
COVID-19 disrupts normal bowel flora
SARS-CoV-2 infection induces an aggressive inflammatory response which is strongly implicated in the cause of multi-organ dysfunction...
-
June 16, 2021Posted: June 16, 2021Read MoreMedieval doctors didn’t always prescribe what was best for an ailing patient (leeches were a popular therapy). However, a medical manuscript from the 10th Century called Bald’s Leechbook recently found in the British Library details a concoction of wine, oxbile, and two species of Allium (garlic, onion, or leek) used to treat styes, now known as an infection caused by Staphylococcus aureus...
